What is LOPJLB’s current signal on ZNTL?

LOPJLB’s latest quantitative signal on Zentalis Pharmaceuticals, Inc. (ZNTL) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ZNTL in?

Zentalis Pharmaceuticals, Inc. (ZNTL) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Zentalis Pharmaceuticals, Inc. (ZNTL) do?

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. T…

Where is Zentalis Pharmaceuticals, Inc. based / listed?

Zentalis Pharmaceuticals, Inc. is based in US, listed on NASDAQ.

Zentalis Pharmaceuticals, Inc. (ZNTL)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.64+5.18%Close

SELLCRISIS · day 22

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $188M
Beta: 1.86
P/E (TTM): -1.09

Short % float: 12.27%
Days to cover: 4.1
SI change: +24.5%

1W: +4.76%
1M: -26.46%

vs SPY 1W: +3.60%
vs SPY 1M: -29.45%

Industry peers

FMP comparable companies · ranked by market cap

STTKSELLShattuck Labs, Inc.$530MCRISISQ 5$5.86+5.48%
IMMXSELLImmix Biopharma, Inc.$524MCRISISQ 24$9.64+1.83%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news